Dr. Charles B. Simone II

Dr. Charles B. Simone II

Radiation Oncologist & Contributing Writer

Radiation oncologist Dr. Charles B. Simone II is the chief medical officer at the New York Proton Center, the only facility in the state that offers proton radiation therapy for pleural mesothelioma patients.

About Dr. Charles B. Simone II

  • American Board of Radiology

  • American Board of Internal Medicine

Fast Facts
  • Simone formerly served as medical director at the University of Maryland Proton Treatment Center.

  • He received his undergraduate degree and medical school training at the University of Pennsylvania. Simone later became director of the Penn Medicine Mesothelioma and Pleural Program.

  • Simone did his residency training in radiation oncology at the National Cancer Institute.

Dr. Charles Simone II is the chief medical officer of the New York Proton Center, a collaborative effort between Mount Sinai Health System, Memorial Sloan Kettering Cancer Center and Montefiore Health System.

The innovative proton center opened in 2019 and is the only one of its kind in the state, bringing the most technologically advanced radiation treatment facility to New York City.

Simone is one of America’s leading authorities and an internationally recognized expert in the use of proton therapy for treating thoracic malignancies such as pleural mesothelioma cancer.

He believes the use of novel proton therapy will improve survival for mesothelioma patients, providing a safer and more effective form of radiation in a multidisciplinary setting.

Before coming to New York City, he pioneered the early use of proton therapy at the University of Pennsylvania’s Abramson Cancer Center and later at the University of Maryland’s Greenebaum Cancer Center.

“The New York Proton Center will be one of the few centers that can safely treat the entire pleura surface that is often necessary with mesothelioma,” he said. “This is going to be the approach of choice in treating this disease.”

Share this article

Last Modified August 3, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now